To test whether IRAK3 deficiency has an effect on tumor growth, syngeneic murine cancer cell lines were injected subcutaneously in age-matched WT or IRAK3 CRISPR-KO mice (Figure 6A). This evidence concerns the gene IRAK3 and cancer.